CRP and penile cancer: High levels of circulating CRP have recently been associated with metastatic disease and a poor prognosis in various malignancies [16-26], including renal cell carcinoma [27,28], urothelial carcinoma [29,30], castration-resistant prostate cancer [31], and even penile cancer [26].